Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLO1 | Q04760 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8282623 | 1.00 | GLO1 (0.48) | GLO1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL1077904 | 1.00 | GLO1 (0.48) | GLO1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL2914885 | 0.88 | ALDH1A1 (0.46) | GLO1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL11509629 | 0.84 | MAPT (0.47) | GLO1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL11509628 | 0.84 | MAPT (0.47) | GLO1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL27280953 | 0.83 | TSHR (0.37) | GLO1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL14159229 | 0.82 | EGLN1 (0.41) | GLO1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL9061777 | 0.82 | GLO1 (0.48) | GLO1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL7766368 | 0.80 | SOAT1 (0.41) | GLO1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL7766372 | 0.80 | SOAT1 (0.41) | GLO1ALDH1A1LMNAHSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118851937-A | Preparation method and device of (Z) -2-methoxyimino-3-oxo-ethyl butyrate | 山东合益气体股份有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-117326974-B | Preparation method of ethyl 2-hydroxyiminoacetoacetate | 山东国邦药业有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-117326974-A | Preparation method of ethyl 2-hydroxyiminoacetoacetate | 山东国邦药业有限公司 | 2024-01-02 | — | — | CN | claimed |
| CN-114031575-B | Preparation method of ethyl northioxomate | 山东金城医药化工有限公司 | 2023-09-12 | — | — | CN | claimed |
| US-11713300-B2 | Platelet aggregation inhibitor, preparation and uses thereof | SHENYANG HINEWY PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2023-08-01 | — | — | US | claimed |
| CN-116283655-A | Continuous production process and system of ethyl 2-hydroxy imine acetoacetate | 青岛科技大学 | 2023-06-23 | — | — | CN | claimed |
| CN-111072515-B | Method for continuously synthesizing thiaminoximic acid intermediate | 普洛药业股份有限公司 | 2023-02-28 | — | — | CN | claimed |
| CN-114031575-A | Preparation method of ethyl noraminothiazoly loximate | 山东金城医药化工有限公司 | 2022-02-11 | — | — | CN | claimed |
| EP-3768260-B1 | OXADIAZOLE COMPOUNDS AS TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS | HOFFMANN LA ROCHE (CH) | 2025-10-08 | — | — | EP | disclosed |
| US-20250122184-A1 | OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS | GENENTECH, INC. (US) | 2025-04-17 | — | — | US | disclosed |
| US-12202824-B2 | Oxadiazole transient receptor potential channel inhibitors | GENENTECH, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| CN-118851937-A | Preparation method and device of (Z) -2-methoxyimino-3-oxo-ethyl butyrate | 山东合益气体股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118851937-A | Preparation method and device of (Z) -2-methoxyimino-3-oxo-ethyl butyrate | 山东合益气体股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-115003778-B | Boron-containing cyclic light-emitting compound and color conversion film comprising same | 日东电工株式会社 | 2024-09-17 | — | — | CN | disclosed |
| US-4152432-A | ANTIBIOTICS | ROUSSEL UCLAF (FR) | 1979-05-01 | — | — | US | disclosed |
| US-4113946-A | Δ2,3 -1,4-Morpholine-2-carboxylic acid derivatives as antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1978-09-12 | — | — | US | disclosed |
| US-4066831-A | ANTIBIOTICS | BRISTOL-MYERS COMPANY (US) | 1978-01-03 | — | — | US | disclosed |
| US-4065623-A | O-2-Isocephem-4-carboxylic acid derivatives as antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1977-12-27 | — | — | US | disclosed |
| US-4012383-A | BACTERICIDES | BRISTOL-MYERS COMPANY (US) | 1977-03-15 | — | — | US | disclosed |
| US-4010178-A | Carbonic acid esters, and the preparation thereof and their use | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1977-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12202824-B2 | Oxadiazole transient receptor potential channel inhibitors | TRPA1, TRPV1, TRPV3 | GLO1 3630/4885ALDH1A1 721/4885LMNA 3183/4885 |
| US-11713300-B2 | Platelet aggregation inhibitor, preparation and uses thereof | TFPI, F12, TFPI2 | GLO1 2074/4885ALDH1A1 1546/4885LMNA 2219/4885 |
| US-20250122184-A1 | OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS | TRPA1, TRPV1, TRPV3 | GLO1 3630/4885ALDH1A1 721/4885LMNA 3183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.